Exploratory factor analysis of SCL90-R symptoms relevant to psychosis

Iranian Journal of Psychiatry

Volumn 6, Issue 4, 2011, Pages 128-132

  Bakhshaie, Jafar ^a   Sharifi, Vandad ^a   Amini, Javad ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b FERDOWSI UNIVERSITY OF MASHHAD   (Iran)

Author keywords

Mental health; Paranoid disorders; Psychological tests; Psychotic symptoms; Statistical factor analysis

Indexed keywords

EID: 84856698085     PISSN: 17354587     EISSN: 20082215     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Derogatis LR. SCL90. Administration, Scoring AND Procedures. Manual-1 for the R (revised) Version and Other Instruments of the Psychopathology Rating Scale Series. Chicago: Johns Hopkins University School of Medicine; 1977.
2. Derogatis LR, Cleary PA. Confirmation of the dimensional structure of the SCL-90: a study in construct validity. J Clin Psychol 1977; 33: 981-89.
3. Schmitz N, Hartkamp N, Kiuse J, Franke GH, Reister G, Tress W. The Symptom Check-List-90-R (SCL-90-R): a German validation study. Qual Life Res 2000; 9: 185-193.
4. Henquet C, Krabbendam L, Spauwen J, Kaplan C, Lieb R, Wittchen HU, et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 2005; 330: 11.
5. Spauwen J, Krabbendam L, Lieb R, Wittchen HU, van Os J. Impact of psychological trauma on the development of psychotic symptoms: relationship with psychosis proneness. Br J Psychiatry 2006; 188: 527-533.
6. Dominguez MD, Wichers M, Lieb R, Wittchen HU, Van Os J. Evidence that onset of clinical psychosis is an outcome of progressively more persistent subclinical psychotic experiences: An 8-year cohort study. Schizophr Bull 2011; 37: 84-93.
7. Fergusson DM, Horwood LJ, Swain-Campbell NR. Cannabis dependence and psychotic symptoms in young people. Psychol Med 2003; 33: 15-21.
8. Compton MT, Kaslow NJ. Self-reported psychotic symptoms predict impulsivity among African-American patients in an urban non-psychiatric medical setting. Psychiatry Res 2005; 135: 35-44.
9. Rossler W, Riecher-Rossler A, Angst J, Murray R, Gamma A, Eich D, et al. Psychotic experiences in the general population: a twenty-year prospective community study. Schizophr Res 2007; 92: 1-14.
10. Rief W, Fichter M. The Symptom Check List SCL-90-R and its ability to discriminate between dysthymia, anxiety disorders, and anorexia nervosa. Psychopathology 1992; 25: 128-138.
11. Breetvelt EJ, Boks MP, Numans ME, Selten JP, Sommer IE, Grobbee DE, et al. Schizophrenia risk factors constitute general risk factors for psychiatric symptoms in the population. Schizophr Res 2010; 120: 184-190.
12. Rossler W, Angst J, Gamma A, Haker H, Stulz N, Merikangas KR, et al. Reappraisal of the interplay between psychosis and depression symptoms in the pathogenesis of psychotic syndromes: results from a twenty-year prospective community study. Eur Arch Psychiatry Clin Neurosci 2011; 261: 11-19.
13. Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med 1983; 13: 595-605.
14. Mirzaei R. [Reliability and Validity of SCL-90-R in Iran; MSc Dissertation in Psychology and Behavioral Sciences]. Tehran: University of Tehran; 1979.
15. Bagheri Yazdi SA, Bolhari J, Shah Mohammadi D. [An epidemiological study of psychological disorders in a rural area (Meibod, Yazd) in Iran]. Andisheh va Raftar 1994; 1: 32-41.
16. Lewis-Beck MS. Factor Analysis and Related Techniques. London: Sage; 1994.
17. Bernstein IH, Garbin CP, Teng KG. Applied Multivariate Analysis. New York: Springer-Verlag; 1988.
18. Nunnaly JC, Bernstein IH. Psychometric Theory 3eds. New York: McGraw-Hill; 1994.
19. Panter AT, Swygert KA, Grant Dahlstrom W, Tanaka JS. Factor analytic approaches to personality item-level data. J Pers Assess 1997; 68: 561-589.
20. van Os J. Is there a continuum of psychotic experiences in the general population? Epidemiol Psichiatr Soc 2003; 12: 242-252.
21. Eisen SV, Leff HS, Schaefer E. Implementing outcome systems: lessons from a test of the BASIS-32 and the SF-36. J Behav Health Serv Res 1999; 26: 18-27.